The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2019

Filed:

May. 18, 2016
Applicant:

Adelaide Research & Innovation Pty Ltd, Adelaide, AU;

Inventors:

Peter Hoffmann, Largs North, AU;

Megan Penno, Mile End, AU;

Matthias Robert Walter Ernst, Victoria, AU;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 33/50 (2006.01); C12Q 1/6886 (2018.01); G01N 33/92 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57446 (2013.01); C12Q 1/6886 (2013.01); G01N 33/5023 (2013.01); G01N 33/57488 (2013.01); G01N 33/92 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01); C12Q 2600/16 (2013.01); G01N 2333/65 (2013.01); G01N 2333/76 (2013.01); G01N 2333/775 (2013.01); G01N 2333/811 (2013.01); G01N 2800/52 (2013.01); G01N 2800/60 (2013.01);
Abstract

The present invention provides biological markers associated with gastric cancer. In particular, the present invention provides a method of diagnosing gastric cancer (GC) in a subject, the method including: measuring an expression level of one or more proteins in the subject, wherein the one or more proteins are selected from the group consisting of vitamin D binding protein (VDBP), clusterin, insulin like growth factor binding protein complex acid labile subunit (IGFALS), and afamin; comparing the expression level of the or each protein in the subject to a reference expression level for the or each protein; and diagnosing GC in the subject on the basis of the comparison. On the basis of the identification of biological markers associated with gastric cancer, the present invention also provides a method of determining if a subject is susceptible to developing gastric cancer, a method of assessing progression of gastric cancer in a subject, a method for screening a candidate therapeutic agent useful for treating gastric cancer in a subject, and a kit for diagnosing gastric cancer in a subject.


Find Patent Forward Citations

Loading…